Drug Type Small molecule drug |
Synonyms Ethacrynate sodium (USP), Xarano, EY 128 + [2] |
Target |
Mechanism GSTP1 inhibitors(Glutathione S-transferase Pi inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (10 Jan 1967), |
Regulation- |
Molecular FormulaC13H12Cl2NaO4 |
InChIKeyOPVSUVQQYHPGOZ-UHFFFAOYSA-N |
CAS Registry6500-81-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04079 | Ethacrynate Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ascites | US | 10 Jan 1967 | |
Edema | US | 10 Jan 1967 | |
Heart Defects, Congenital | US | 10 Jan 1967 | |
Nephrotic Syndrome | US | 10 Jan 1967 |